A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
NCT07414602 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-03-18
Summary
The Phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1894 in healthy subjects.
Conditions
- Dermatitis
Interventions
- DRUG
-
SHR-1894 Injection
SHR-1894 injection.
- DRUG
-
SHR-1894 Injection Placebo
SHR-1894 injection placebo.
Sponsors & Collaborators
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-16
- Primary Completion
- 2026-10-31
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
NCT05244304 ·Status: COMPLETED ·Phase: PHASE3
-
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
NCT04774809 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
NCT01614743 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
NCT07340697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis
NCT06824870 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
NCT05247489 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea
NCT01828177 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
NCT06108024 ·Status: RECRUITING ·Phase: PHASE2
-
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
NCT05231044 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo
NCT06394349 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
NCT07013747 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
NCT04476043 ·Status: COMPLETED ·Phase: PHASE2
-
Study of A-101 for the Treatment of Seborrheic Keratosis
NCT02260180 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne
NCT06378983 ·Status: RECRUITING ·Phase: NA
-
A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.
NCT07318675 ·Status: RECRUITING ·Phase: PHASE1
-
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
NCT01838499 ·Status: TERMINATED ·Phase: PHASE2
-
Study of SOR007 Ointment for Actinic Keratosis
NCT03083470 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)
NCT00483496 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
NCT06316297 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers
NCT01863160 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
NCT02806414 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
NCT01922050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00014729 ·Status: COMPLETED ·Phase: PHASE1
-
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
NCT03846531 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
NCT02250430 ·Status: COMPLETED ·Phase: PHASE1